10 Outstanding Companies for Women ’s Health

The women’s health technology or so-called femtech market has been on the rise for the last couple of years, but it has mainly revolved around fertility and pregnancy. We believe that female health topics reach far beyond such traditional issues and players should concentrate more on menopause, endometriosis, or mental health, just to name a few areas. Thus, we tried to collect companies which are on top of their game in the conventional fertility and/or pregnancy area, but also start-ups and ventures who are looking way beyond that. Here’s our guide to 10 outstanding companies in women’s health. The women’s health market is burgeoning We’ve come a long way in the last couple of years from women’s health issues considered as taboos – women growing up in the 1980s or 1990s could surely relate to obsessively checking the back of their trousers for any sign of their periods coming too early and feeling embarrassed by the idea of anyone else knowing about it – to being openly talked about and even facilitated by digital health technologies. Two New York City high school girls even developed a video game called “Tampon Run” – the heroine’s mission is “to rid the world of the menstrual taboo.” As technology companies slowly recognized that the area is far from being a niche market, and women started to increasingly use digital health or better say, “femtech” products for female ...
Source: The Medical Futurist - Category: Information Technology Authors: Tags: Business Future of Medicine Health Sensors & Trackers Telemedicine & Smartphones companies company digital digital health digital health technologies femtech health technology Innovation market women women's health Source Type: blogs

Related Links:

Publication date: Available online 18 October 2019Source: IJC Heart &VasculatureAuthor(s): Dominik Linz, Mathias Baumert, Lien Desteghe, Kadhim Kadhim, Kevin Vernooy, Jonathan M. Kalman, Dobromir Dobrev, Michael Arzt, Manu Sastry, Harry J.G.M. Crijns, Ulrich Schotten, Martin R. Cowie, R. Doug McEvoy, Hein Heidbuchel, Jeroen Hendriks, Prashanthan Sanders, Dennis H. LauAbstractIn patients with atrial fibrillation (AF), the prevalence of moderate-to-severe sleep-disordered breathing (SDB) ranges between 21% and 72% and observational studies have demonstrated that SDB reduces the efficacy of rhythm control strategies, whil...
Source: IJC Heart and Vasculature - Category: Cardiology Source Type: research
Publication date: Available online 19 October 2019Source: Practical Radiation OncologyAuthor(s): Barry S. Rosenstein
Source: Practical Radiation Oncology - Category: Cancer & Oncology Source Type: research
ConclusionThese findings suggest that targeted research and interventions are necessary to address the specific needs of rural lymphoma patients and survivors. To address the disparity in health outcomes within rural populations, health care professionals and investigators can utilize these data to engage rural patients in treatment decision-making and research planning.
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research
ConclusionThe better prognosis in young patients is presumably due to their better physiological reserve and lower incidence of comorbidities. Efforts should be made in younger patients to diagnose early and treat aggressively.
Source: Cancer Epidemiology - Category: Cancer & Oncology Source Type: research
We examined racial differences in hospitalization outcomes; length of stay (LOS) in hospital, mortality in hospital, post-operative complications in patients who underwent hysterectomy and discharge disposition. Patients were matched on age at primary diagnosis, insurance status, residential region, and median income of residential area, modified Deyo comorbidity index, stage of disease and treatment. Categorical outcomes were analyzed by conditional logistic regression accounting for matched study design and odds ratios (95%CI) were reported. LOS was analyzed using t-test and beta estimate for difference in means was repo...
Source: Cancer Epidemiology - Category: Cancer & Oncology Source Type: research
Publication date: Available online 18 October 2019Source: Acta Pharmaceutica Sinica BAuthor(s): Hui Deng, Weimin LiAbstractMonoacylglycerol lipase (MAGL) is a serine hydrolase that plays a crucial role catalysing the hydrolysis of monoglycerides into glycerol and fatty acids. It links the endocannabinoid and eicosanoid systems together by degradation of the abundant endocannabinoid 2-arachidaoylglycerol into arachidonic acid, the precursor of prostaglandins and other inflammatory mediators. MAGL inhibitors have been considered as important agents in many therapeutic fields, including anti-nociceptive, anxiolytic, anti-infl...
Source: Acta Pharmaceutica Sinica B - Category: Cancer & Oncology Source Type: research
Publication date: Available online 18 October 2019Source: Acta Pharmaceutica Sinica BAuthor(s): Honggang Xiang, Jifa Zhang, Congcong Lin, Lan Zhang, Bo Liu, Liang OuyangAbstractAutophagy, defined as a scavenging process of protein aggregates and damaged organelles mediated by lysosomes, plays a significant role in the quality control of macromolecules and organelles. Since protein kinases are integral to the autophagy process, it is critically important to understand the role of kinases in autophagic regulation. At present, intervention of autophagic processes by small-molecule modulators targeting specific kinases has bec...
Source: Acta Pharmaceutica Sinica B - Category: Cancer & Oncology Source Type: research
Publication date: Available online 18 October 2019Source: Acta Pharmaceutica Sinica BAuthor(s): Zongru Jiang, Li Wang, Xuesong Liu, Cheng Chen, Beilei Wang, Wenliang Wang, Chen Hu, Kailin Yu, Ziping Qi, Qingwang Liu, Aoli Wang, Jing Liu, Guangchen Hong, Wenchao Wang, Qingsong LiuAbstractAngiogenesis is an essential process in tumor growth, invasion and metastasis. VEGF receptor 2 (VEGFR2) inhibitors targeting tumor angiogenic pathway have been widely used in the clinical cancer treatment. However, most of currently used VEGFR2 kinase inhibitors are multi-target inhibitors which might result in target-associated side effect...
Source: Acta Pharmaceutica Sinica B - Category: Cancer & Oncology Source Type: research
Source: Journal of Cancer Research and Clinical Oncology - Category: Cancer & Oncology Source Type: research
AbstractPurposeThe identification of biomarkers characterizing the invasive potential of bladder cancer could enhance the clinical management of individual patients and therefore improve prognosis. The aim of this study was to define a miRNA panel in tumor tissues as well as in urinary extracellular vesicles (EVs) for discriminating muscle-invasive bladder cancer (MIBC) from non-muscle-invasive bladder cancer (NMIBC).MethodsmiRNA expression was analyzed in 24 formalin-fixed, paraffin-embedded (FFPE) tumor samples by microarray analysis and was further validated by qRT-PCR in 56 FFPE tumor samples as well as in 37 urinary E...
Source: Journal of Cancer Research and Clinical Oncology - Category: Cancer & Oncology Source Type: research
More News: Anxiety | Babies | Babies Heart Conditions | Back Pain | Bladder Cancer | Breast Cancer | Breastfed | Cancer | Cancer & Oncology | Cancer in Adolescents | Cardiology | Cervical Cancer | Children | Education | Endometriosis | Environmental Health | Ethiopia Health | Girls | Heart | Hormones | Hospitals | Incontinence | India Health | Information Technology | Insomnia | Israel Health | Learning | Medical Devices | Men | Menopause | Middle East Health | Midwifery | Pain | Perfusion | Pre-eclampsia | Pregnancy | Pregnancy and Breast Cancer | Reproduction Medicine | Science | Skin | Sleep Disorders | Sleep Medicine | Somalia Health | Statistics | Study | Sweden Health | Switzerland Health | Universities & Medical Training | Women